A total of 183 recent Staphylococcus aureus clinical isolates were tested with three commercially available rapid agglutination methods. The capsular polysaccharide type and resistance to oxacillin of these isolates were also determined. Seven isolates were not identified correctly by agglutination methods. All isolates not identified by the rapid methods were of capsular serotype 5, and of these isolates, six were resistant to oxacillin. The results suggest that these agglutination kits can be improved by the use of antibodies reactive with S. aureus capsular polysaccharide.
Rapid procedures capable of distinguishing Staphylococcus aureus from coagulase-negative staphylococci have been developed. These methods use either latex particles coated with human plasma for the simultaneous detection of protein A and clumping factor (8) or sheep erythrocytes sensitized with fibrinogen for the detection of clumping factor (9) . Commercially available systems using these methods have been evaluated in clinical situations, and the results have been controversial. Although most of these evaluations have shown good correlation with reference methods (1, 3, 6-8, 12, 14-17, 20, 22) , some reports have noted that oxacillinresistant S. aureus isolates may yield false-negative reactions with these kits (1, 4, 18, 21, 25) .
Capsular polysaccharides have been characterized in clinical isolates of S. aureus in humans (13) . Surveys have shown that two capsular serotypes, 5 and 8, account for about 70 to 80% of serological types (2, 11, 23) . A predominance of capsular serotype 5 among oxacillin-resistant S. aureus isolates has also been described (10) .
In 5 . Of these isolates, six were resistant to oxacillin (MIC, >64 ,ug/ml) and also to several other antibiotics such as aminoglycoside, tetracycline, and clindamycin. The source, the MIC of oxacillin, and the phage pattern for each of these isolates are listed in Table 1 . The diverse characteristics of these isolates show that they do not constitute a unique clone which could have disseminated in Parisian hospitals.
In our study, rapid agglutination tests correctly identified 132/133 (99%) oxacillin-susceptible S. aureus isolates. If we consider the total of oxacillin-susceptible (n = 133) and oxacillin-resistant (n = 50) S. aureus isolates studied, these tests correctly identified 176 (96%) isolates. These results agreed with previous studies with these rapid test methods which reported sensitiVities of 95 to 100% (1, 3, 6-8, 12, 14-17, 2d, 22 (11) . However, further microscopic studies of the various antigens exposed on the surface of S. aureus bacterial cells are necessary to examine this hypothesis.
The observation that S. aureus isolates which are not identified by rapid agglutination methods do possess capsular polysaccharide offers the possibility of improving these currently available agglutination kits by adding to these reagents particles sensitized with antibodies which react with S. aureus capsular polysaccharide. Such improvement may be applicable for the preparation of rapid agglutination kits reliable for both oxacillin-susceptible and oxacillinresistant S. aureus isolates.
